Ultragenyx Pharmaceutical【RARE】株式ニュース

名称	銘柄コード	市場	種別
Ultragenyx Pharmaceutical Inc	RARE	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	1.49	3.86%	40.14	09:00:00

始値	安値	高値	終値	前日終値
39.68	39.14	40.74	40.14	38.65

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/5/31	05:04	EDGAR2	Form 8-K - Current report
2024/5/31	05:00	GLOBE	Ultragenyx Announces Positive Top-Line Results from Phase 3..
2024/5/18	05:30	GLOBE	Ultragenyx Reports Inducement Grant Under Nasdaq Listing..
2024/5/08	05:30	GLOBE	Ultragenyx to Participate at Bank of America’s 2024..
2024/5/03	05:00	GLOBE	Ultragenyx Reports First Quarter 2024 Financial Results and..
2024/5/01	05:00	GLOBE	Ultragenyx Issues 2023 Corporate Responsibility Report,..
2024/4/30	21:00	GLOBE	Ultragenyx Announces Completion of Enrollment in Phase 3..
2024/4/26	05:30	GLOBE	Ultragenyx to Host Conference Call for First Quarter 2024..
2024/4/20	05:30	GLOBE	Ultragenyx Reports Inducement Grant Under Nasdaq Listing..
2024/4/15	20:00	GLOBE	Ultragenyx Announces Positive Interim Phase 1/2 Data in..
2024/4/13	05:22	GLOBE	Ultragenyx Announces Update to Conference Call Timing to..
2024/4/12	21:00	GLOBE	Ultragenyx Announces Upcoming Data Presentations at American..
2024/3/23	05:00	GLOBE	Ultragenyx Reports Inducement Grant Under Nasdaq Listing..
2024/3/06	10:23	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/06	10:22	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/06	10:17	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/06	10:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/06	10:13	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/06	10:10	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/06	10:08	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/28	06:30	GLOBE	Ultragenyx to Participate at Investor Conferences in March
2024/2/24	06:05	GLOBE	Ultragenyx Reports Inducement Grant Under Nasdaq Listing..
2024/2/22	07:03	EDGAR2	Form S-3ASR - Automatic shelf registration statement of..
2024/2/16	06:04	EDGAR2	Form 8-K - Current report
2024/2/16	06:01	GLOBE	Ultragenyx Reports Fourth Quarter and Full Year 2023..
2024/2/09	06:00	GLOBE	Ultragenyx to Host Conference Call for Fourth Quarter and..
2024/2/06	22:00	GLOBE	Ultragenyx Announces Data Demonstrating Treatment with UX111..
2024/2/06	06:05	GLOBE	Ultragenyx Receives PRIME Designation from European..
2024/1/26	06:05	GLOBE	Ultragenyx Announces Completion of Dosing Across Stage 1..
2024/1/20	06:00	GLOBE	Ultragenyx Reports Inducement Grant Under Nasdaq Listing..
2024/1/08	21:00	GLOBE	Mereo BioPharma Provides Update on Pipeline Progress and..
2024/1/08	20:03	EDGAR2	Form 8-K - Current report
2024/1/08	01:00	GLOBE	Ultragenyx Reports Preliminary 2023 Revenue; Guidance for..
2024/1/04	22:00	GLOBE	Ultragenyx Receives Positive Recommendation from NICE in the..
2024/1/03	22:00	GLOBE	Ultragenyx Announces Completion of Enrollment in Global..
2024/1/03	06:06	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/03	06:05	GLOBE	Ultragenyx to Present at the 42nd Annual J.P. Morgan..
2023/12/22	07:45	DJN	Ultragenyx to Pay $6 Million to Settle Alleged False..
2023/12/22	06:30	GLOBE	Ultragenyx Reports Inducement Grant Under Nasdaq Listing..
2023/12/22	06:02	EDGAR2	Form 8-K - Current report
2023/12/18	22:00	GLOBE	Ultragenyx Receives European Commission Decision for..
2023/11/21	06:30	GLOBE	Ultragenyx to Participate at Investor Conferences in..
2023/11/18	06:30	GLOBE	Ultragenyx Reports Inducement Grant Under Nasdaq Listing..
2023/11/08	07:00	GLOBE	Ultragenyx to Participate in the Jefferies London Healthcare..
2023/11/03	05:17	EDGAR2	Form 8-K - Current report
2023/11/03	05:05	GLOBE	Ultragenyx Reports Third Quarter 2023 Financial Results and..
2023/10/27	05:05	GLOBE	Ultragenyx to Host Conference Call for Third Quarter 2023..
2023/10/24	05:01	GLOBE	Ultragenyx Announces Closing of Public Offering of Common..
2023/10/23	19:31	EDGAR2	Form 8-K - Current report
2023/10/21	05:00	GLOBE	Ultragenyx Reports Inducement Grant Under Nasdaq Listing..